Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2023-03-27 (3 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BAYONNE (64100), Pyrenees-Atlantiques
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE RONCIER : revenue, balance sheet and financial ratios
SELARL PHARMACIE RONCIER is a French company
founded 3 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BAYONNE (64100),
this company of category PME
shows in 2025 a net income negative of -13 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE RONCIER (SIREN 950991158)
Indicator
2025
2024
Revenue
N/C
N/C
Net income
-12 983 €
-104 871 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE RONCIER records a net loss of 13 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-12 983 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1027%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 7%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1026.867%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
7.47%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2024
2025
Debt ratio
1038.081
1026.867
Financial autonomy
7.646
7.47
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
1026.872025
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch
In 2025, the debt ratio of SELARL PHARMACIE RONCIER (1026.87) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
7.47%2025
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch
In 2025, the financial autonomy of SELARL PHARMACIE RONCIER (7.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 159.19. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2024
2025
Liquidity ratio
151.939
159.189
Interest coverage
None
None
Sector positioning
Liquidity ratio
159.192025
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average
In 2025, the liquidity ratio of SELARL PHARMACIE RONCIER (159.19) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE RONCIER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE RONCIER with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE RONCIER
What is the revenue of SELARL PHARMACIE RONCIER ?
The revenue of SELARL PHARMACIE RONCIER is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE RONCIER profitable?
SELARL PHARMACIE RONCIER recorded a net loss in 2025.
Where is the headquarters of SELARL PHARMACIE RONCIER ?
The headquarters of SELARL PHARMACIE RONCIER is located in BAYONNE (64100), in the department Pyrenees-Atlantiques.
Where to find the tax return of SELARL PHARMACIE RONCIER ?
The tax return of SELARL PHARMACIE RONCIER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE RONCIER operate?
SELARL PHARMACIE RONCIER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart